✦ LIBER ✦

Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension

✍ Scribed by E. G. Giannini; M. Basso; V. Savarino; A. Picciotto

Book ID: 108863662
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 280 KB
Volume: 266
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.2009.02130.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive value of the variceal pressur

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

✍ Àngels Escorsell; Josep Maria Bordas; Beatriz Castañeda; Josep Llach; Joan Carle 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Hepatic function is a strong predictive

Hepatic function is a strong predictive factor of efficacy and safety of antiviral therapy in portal hypertensive hepatitis C virus-related liver cirrhosis

✍ B.E. Annicchiarico; M. Siciliano; P. Parente; A. Gasbarrini; G. Bombardieri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

[568] HEPATIC FUNCTION IS A STRONG PREDI

[568] HEPATIC FUNCTION IS A STRONG PREDICTIVE FACTOR OF EFFICACY AND SAFETY OF ANTIVIRAL THERAPY IN PORTAL HYPERTENSIVE HEPATITIS C VIRUS-RELATED LIVER CIRRHOSIS

✍ B.E. Annicchiarico; M. Siciliano; P. Parente; A. Gasbarrini; G. Bombardieri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Liver stiffness measurement as a predict

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis

✍ M. LEMOINE; S. KATSAHIAN; M. ZIOL; P. NAHON; N. GANNE-CARRIE; F. KAZEMI; V. GRAN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

Impact of IL28B on treatment outcome in

Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin

✍ Thomas-Matthias Scherzer; Albert Friedrich Stättermayer; Michael Strasser; Herma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

The IL28B genotype is the most important pretreatment predictor of treatment outcome in patients with chronic hepatitis C. The impact of the rs12979860 genotype on relapse was retrospectively evaluated in genotype 1/4 patients who received response-guided therapy with peginterferon alpha-2a 180 μg/w

Prediction of sustained response to low-

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation

✍ Hideyuki Tamai; Naoki Shingaki; Tatsuya Shiraki; Hiroshi Tukuda; Yoshiyuki Mori; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB